C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CCCC | AMGN | VRTX | BMY | GILD |
| Company | C4 Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 4.08 | 266.05 | 468.07 | 57.70 | 92.82 |
| High | 4.08 | 266.05 | 474.18 | 57.70 | 92.82 |
| Low | 4.08 | 266.05 | 465.62 | 57.70 | 92.82 |
| Last | 4.08 | 266.05 | 469.24 | 57.70 | 92.82 |
| Change | +0.03 | +0.10 | +1.15 | +0.05 | +0.02 |
| % Change | +0.74% | +0.04% | +0.25% | +0.09% | +0.02% |
| Volume | 14,243 | 78,791 | 1,304,800 | 6,013 | 57,265 |
| 20-Day Average Volume | 1,614,717 | 4,455,035 | 1,279,885 | 9,056,631 | 6,136,088 |
| Previous Close | 4.05 | 265.95 | 468.09 | 57.65 | 92.80 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.25 | 278.04 | 462.37 | 58.15 | 91.81 |
| 20-Day Raw Stochastic | 23.31% | 20.87% | 77.06% | 47.16% | 73.40% |
| 20-Day Relative Strength | 41.70% | 30.71% | 49.75% | 54.05% | 56.44% |
| Weighted Alpha | -27.28 | -13.33 | +12.58 | +18.98 | +25.76 |
| Today's Opinion | 100% Sell | 88% Sell | 24% Sell | 80% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 24% Sell | 80% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.38% since 12/11/24 | -2.69% since 12/11/24 | unch since 12/10/24 | +1.85% since 12/11/24 | +0.48% since 12/11/24 |
| Low | 3.99 on 12/17/24 | 264.81 on 12/17/24 | 459.79 on 12/13/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 |
| High | 4.70 on 12/12/24 | 275.88 on 12/12/24 | 474.18 on 12/17/24 | 57.77 on 12/17/24 | 93.59 on 12/17/24 |
| 1-Month | |||||
| %Chg | -2.86% since 11/18/24 | -4.56% since 11/18/24 | +0.76% since 11/15/24 | +1.58% since 11/18/24 | +4.93% since 11/18/24 |
| Low | 3.77 on 12/05/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 55.04 on 12/13/24 | 86.08 on 11/19/24 |
| High | 5.10 on 12/09/24 | 297.32 on 11/25/24 | 476.46 on 12/10/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 |
| 3-Month | |||||
| %Chg | -36.05% since 09/18/24 | -20.09% since 09/18/24 | -2.50% since 09/17/24 | +16.00% since 09/18/24 | +10.64% since 09/18/24 |
| Low | 3.77 on 12/05/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 48.94 on 09/19/24 | 81.83 on 09/26/24 |
| High | 7.14 on 10/16/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | unch since 06/18/24 | -13.05% since 06/18/24 | -0.94% since 06/17/24 | +41.39% since 06/18/24 | +46.98% since 06/18/24 |
| Low | 3.77 on 12/05/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 39.35 on 07/05/24 | 64.86 on 06/20/24 |
| High | 7.66 on 07/16/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 285,885 | 142,956,912 | 120,842,896 | 116,924,408 | 115,653,488 |
| Shares Outstanding, K | 70,589 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 20,760,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -132,490,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 15,360,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -24,670,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 2.92 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 10/31/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/06/24 | 02/04/25 | 02/03/25 | 02/06/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 01/03/25 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.87 | 0.00 | 47.75 | 20.78 |